Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients
AIM To explore the natural history of covert hepatic encephalopathy(CHE) in absence of medication intervention.METHODS Consecutive outpatient cirrhotic patients in a Chinese tertiary care hospital were enrolled and evaluated for CHE diagnosis. They were followed up for a mean of 11.2 ± 1.3 mo. Time...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 23; no. 34; pp. 6321 - 6329 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
14.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM To explore the natural history of covert hepatic encephalopathy(CHE) in absence of medication intervention.METHODS Consecutive outpatient cirrhotic patients in a Chinese tertiary care hospital were enrolled and evaluated for CHE diagnosis. They were followed up for a mean of 11.2 ± 1.3 mo. Time to the first cirrhosis-related complications requiring hospitalization, including overt HE(OHE), resolution of CHE and death/transplantation, were compared between CHE and no-CHE patients. Predictors for complication(s) and death/transplantation were also analyzed.RESULTS A total of 366 patients(age: 47.2 ± 8.6 years, male: 73.0%) were enrolled. CHE was identified in 131 patients(35.8%). CHE patients had higher rates of death and incidence of complications requiring hospitalization, including OHE, compared to unimpaired patients. Moreover, 17.6% of CHE patients developed OHE, 42.0% suffered persistent CHE, and 19.8% of CHE spontaneously resolved. In CHE patients, serum albumin < 30 g/L(HR = 5.22, P = 0.03) was the sole predictor for developing OHE, and blood creatinine > 133 μmol/L(HR = 4.75, P = 0.036) predicted mortality. Child-Pugh B/C(HR = 0.084, P < 0.001) and OHE history(HR = 0.15, P = 0.014) were predictors of spontaneous resolution of CHE.CONCLUSION CHE exacerbates, persists or resolves without medication intervention in clinically stable cirrhosis. Triage of patients based on these predictors will allow for more cost-effect management of CHE. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 Author contributions: Wang AJ and Zhu X designed the research; Wang AJ, Li BM, Gan N, Pei L, Hong JB, Xiao HY and Zhong JW followed up with the patients and performed the research; Zheng XL analyzed the data; Wang AJ, Peng AP and Zhu X wrote the paper. Supported by Science and Technology Planning Project of Health and Family Planning Commission of Jiangxi Province, No. 20171022; National Natural Science Fund of China, No. 81460122; Project in the Science and Technology Pillar Program of Jiangxi Provincial Department of Science and Technology, No. 20161BBG70166; Jiangxi Provincial Outstanding Young Talent Program, No. 20171BCB23085; and Natural Science Fund of Jiangxi Province For Young Scholars, No. 20171BAB215008. Correspondence to: Xuan Zhu, MD, Professor, Chief, Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zheng Street, Nanchang 330006, Jiangxi Province, China. ndyfy0326@ncu.edu.cn Telephone: +86-791-88692505 Fax: +86-791-88623153 |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v23.i34.6321 |